# Audit: original-plan remaining gap closure roadmap

## Date

2026-05-05

## Scope

This note audits
`docs/plans/bayesfilter-original-plan-remaining-gap-closure-roadmap-2026-05-05.md`
as if reviewed by a separate developer before execution.

## Audit Findings

### Finding A1: dependency order is correct

The roadmap puts workspace hygiene and provenance before implementation, DSGE
metadata before client-facing structural particle/HMC claims, factor-backend
classification before spectral derivative certification, and sampler
diagnostics after target and provider evidence.  That order is necessary and
should be preserved.

### Finding A2: phase closure must distinguish BayesFilter gates from client
promotion

Some phases can close inside BayesFilter:

- structural adapter gates;
- particle-filter semantics for BayesFilter toy models;
- factor-backend and spectral-derivative metadata gates;
- MacroFinance readiness gates that consume provider-owned evidence;
- HMC diagnostic gates over supplied chain diagnostics.

Other phases cannot be honestly closed from BayesFilter alone:

- DSGE SmallNK/Rotemberg/SGU/EZ adapter implementation in `/home/chakwong/python`;
- final MacroFinance ten-country production promotion in
  `/home/chakwong/MacroFinance`;
- real HMC convergence labels without actual chain output.

The execution should therefore close BayesFilter-owned gates and record client
promotion blockers rather than claiming that client repositories were changed.

### Finding A3: no missing gap in the roadmap

The roadmap covers the remaining original-plan gaps:

- DSGE adapter pilot;
- particle-filter semantics;
- factor-backend and derivative-hook audit;
- SVD/eigen derivative certification;
- MacroFinance expanded-provider evidence;
- HMC sampler readiness;
- release-quality documentation and literature gates.

The only sharpening needed was an explicit blocker register and reset-memo
logging rule, both now present in the roadmap.

### Finding A4: execution risk is overclaiming, not missing implementation

The highest risk is turning an executable gate into a stronger scientific
claim.  The safe labels are:

- `adapter_ready` for metadata gates only;
- `monte_carlo_value_only` for the particle reference path;
- `target_candidate` only when value, derivative, and compiled gates pass;
- `diagnostics_thresholds_passed` only for supplied chain diagnostics;
- `not_claimed` for convergence unless strict multi-chain evidence exists.

## Audit Decision

No blocking issue for BayesFilter-owned execution.  Proceed phase by phase, but
stop short of client-repository promotion claims unless the client evidence is
available and tested.
